Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Pfizer
Current Parent CompanyPfizer
Parent at the Time of the Penalty Announcement subscribe to see this data field
Penalty: $745,000,000
Year: 2008
Date: October 17, 2008
Offense Group: safety-related offenses
Primary Offense: drug or medical equipment safety violation
Secondary Offense: product safety violation
Mega-ScandalPharmaceutical Hazards
Violation Description: In October 2008 Pfizer said it was taking a charge of $894 million to cover litigation costs relating to its anti-inflammatory drugs Bextra and Celebrex. Of the total, $745 million was to cover product liability suits relating to the two drugs.
Level of Government: federal
Action Type: private litigation
Court: Northern District of California
Civil or Criminal Case: civil
Case ID: 3:05md1699
Case Name: In Re Bextra And Celebrex Marketing, Sales Practices And Products Liability
Private Lawsuit Resolution Type: settlement
HQ Country of Current Parent: USA
HQ State of Current Parent: New York
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data(click here)
Link to PACER Case Docket (must be logged in)(click here)
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.